黄芩素
黄芩
益生元
肠道菌群
胰岛素抵抗
2型糖尿病
类黄酮
糖尿病
生物利用度
内分泌学
链脲佐菌素
药理学
化学
医学
生物
食品科学
生物化学
抗氧化剂
替代医学
中医药
病理
作者
Bowei Zhang,Wenlong Sun,Na Yu,Jin Sun,Xiaoxia Yu,Xia Li,Yan Xing,Dong Yan,Qianzhi Ding,Zhilong Xiu,Baiping Ma,Liyan Yu,Yuesheng Dong
标识
DOI:10.1016/j.jff.2018.04.070
摘要
Baicalein, a dietary flavonoid, is the major constituent of Oroxylum indicum and Scutellaria baicalensis which are consumed as teas or dietary supplements in Asia, European, and the United States. The compound exhibits a variety of bioactivities despite its limited bioavailability. In the present work, 4-week treatment of baicalein significantly decreased the levels of blood glucose and circulating lipopolysaccharide (LPS) and improved insulin resistance, inflammation, and lipid profile in diabetic rats induced by STZ and high-fat-high-sugar-diet. These anti-diabetic effects were attributed to the increased SCFAs content and the increased thickness of gut mucus layer, and were associated with the modulation of gut microbiota. Among the key phylotypes, Bacteroides and Bacteroidales S24-7 had the highest relative abundance in the rats receiving high-dose baicalein and showed positive correlation with the phenotypes related to the improvement of type 2 diabetes (T2DM). Our study supports the use of baicalein as a dietary supplement and a potential prebiotic for its ability to modify gut microbiota and to improve T2DM-related biochemical abnormalities.
科研通智能强力驱动
Strongly Powered by AbleSci AI